SBI Securities
HCAT icon

SBI Securities’s Health Catalyst HCAT Stock Holding History

SBI Securities’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.36K Sell
1,188
-38
-3% -$55 ﹤0.01% 2497
2026
Q1 		$1.56K Sell
1,226
-84
-6% -$158 ﹤0.01% 2494
2025
Q4 		$3.13K Hold
1,310
– – ﹤0.01% 2218
2025
Q3 		$3.73K Hold
1,310
– – ﹤0.01% 2169
2025
Q2 		$4.94K Hold
1,310
– – ﹤0.01% 1988
2025
Q1 		$5.93K Sell
1,310
-39
-3% -$206 ﹤0.01% 1829
2024
Q4 		$9.54K Buy
+1,349
New +$10.7K ﹤0.01% 1666

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $239M AUM
PVM
Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SBI Securities's HCAT Position: Q2 2026 in Review

SBI Securities reduced its Health Catalyst (HCAT) stake by 3.1% in Q2 2026, selling an estimated $55 and leaving 1,188 shares worth $2.36K. The position accounts for ﹤0.01% of the portfolio, ranked #2497.

SBI Securities first reported a position in HCAT in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.54K in Q4 2024. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • SBI Securities held 1,188 shares of Health Catalyst worth $2.36K as of Q2 2026.
  • SBI Securities sold 38 Health Catalyst shares in Q2 2026, an estimated $55.
  • Health Catalyst made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #2497 holding.
  • SBI Securities first reported a position in Health Catalyst in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Health Catalyst position peaked at $9.54K in Q4 2024.
  • 126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.